CompoAtlas

Equate Glucosamine Chondroitin

Natural health product licensed in Canada

Other names
Equate Glucosamine 300 mg and Chondroitin 200 mg, Equate Glucosamine Chondroitin 500 mg
Licence holder
Nutricorp International
NPN or DIN-HM
80080942
Status
Active licence
Licence date
30 October 2017
Revision date
Not provided
Form
Capsule, molle
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose

Source : Exosquelette de crevette

300 mgNot calculated
Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose

Source : Exosquelette de crabe

300 mgNot calculated
Sulfate de chondroïtine

Source : Bos taurus - cartilage

200 mgNot calculated

Non-medicinal ingredients

Cire d'abeille, Huile de fève de soja, Lécithine, Dioxyde de titane, Gélatine, Glycérine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years2 Capsule3 Tous les jours

Uses authorised in Canada

Helps to relieve (joint) pain associated with osteoarthritis (of the knee). Helps to maintain healthy cartilage/joint health. A factor in maintaining healthy cartilage. A factor in maintaining joint health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80080942

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line